Jazz Pharmaceuticals plc company logo
Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc (JAZZ) EBITDA

Annual EBITDA

$1.45B$60.72M+4.38%

Summary

Current Value
As of today, JAZZ annual EBITDA is $1.45B, up +4.38% on
Historical Performance
JAZZ annual EBITDA is up +7.24% over the past 3 years, up +38.68% over the past 5 years
All-Time High Comparison
JAZZ annual EBITDA is currently at its all-time high
3-Year Low Comparison
JAZZ annual EBITDA is +11.51% above its 3-year low of $1.30B reached on
Sector Comparison
JAZZ annual EBITDA is higher than 94.35% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

JAZZ Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA$1.45B+4.4%+7.2%+38.7%+2076.6%
Quarterly EBITDA$433.70M+20.8%+69.2%+54.3%+1473.1%
TTM EBITDA$1.28B-8.0%+8.0%+22.2%+1817.9%
Price$182.01+33.4%+27.5%+10.5%+571.4%
PE Ratio-
Annual Revenue$4.27B+4.9%+16.6%+80.6%+2355.7%
Annual EPS-$5.84-167.5%-63.0%-238.3%-803.6%
$751.12M+3.4%+4.3%-1.9%+1199.8%
Annual Net Income-$356.15M-163.6%-59.0%-249.3%-1186.5%

EBITDA Highs

JAZZ Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y$1.45Bat high
5Y$1.45Bat high
All$1.45Bat high

EBITDA Lows

JAZZ Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y$1.30B+11.5%
5Y$951.76M+52.1%
All-$122.08M+1285.7%

EBITDA History

YearValueChange
$1.45B+4.4%
$1.39B+6.8%
$1.30B-3.8%
$1.35B+41.8%
$951.76M-8.8%
$1.04B+3.1%
$1.01B+15.7%
$874.97M+12.3%
$779.00M+5.2%
$740.68M+14.0%
$649.64M+10.0%
YearValueChange
$590.50M+32.6%
$445.30M+40.3%
$317.48M+116.2%
$146.86M+120.8%
$66.50M+165.7%
$25.03M+120.5%
-$122.08M-34.7%
-$90.62M-33.8%
-$67.74M-31.0%
-$51.71M-104.2%
-$25.33M-

FAQ

  • What is the current annual EBITDA of JAZZ?

    As of today, JAZZ annual EBITDA is $1.45B

  • What is 1-year change in JAZZ annual EBITDA?

    JAZZ annual EBITDA is up +4.38% year-over-year

  • What is 3-year change in JAZZ annual EBITDA?

    JAZZ annual EBITDA is up +7.24% over the past 3 years

  • How far is JAZZ annual EBITDA from its all-time high?

    JAZZ annual EBITDA is currently at its all-time high

  • How does JAZZ annual EBITDA rank versus sector peers?

    JAZZ annual EBITDA is higher than 94.35% of companies in Healthcare sector

  • When is JAZZ next annual earnings release?

    As of today, the next annual earnings release for JAZZ has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

  1. JAZZ Official Website www.jazzpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1232524/000123252426000013/0001232524-26-000013-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1232524/000123252426000013/0001232524-26-000013-index.htm
  4. JAZZ Profile on Yahoo Finance finance.yahoo.com/quote/JAZZ
  5. JAZZ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jazz